Edition:
India

Livzon Pharmaceutical Group Inc (1513.HK)

1513.HK on Hong Kong Stock

23.65HKD
14 Jun 2019
Change (% chg)

HK$-0.30 (-1.25%)
Prev Close
HK$23.95
Open
HK$23.95
Day's High
HK$23.95
Day's Low
HK$23.40
Volume
557,310
Avg. Vol
893,298
52-wk High
HK$44.85
52-wk Low
HK$20.05

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 2,607.55 0.550
FY 2018 Dec '18 2,019.22 0.199
Sep '18 2,276.73 0.430
Jun '18 2,195.58 0.397
Mar '18 2,369.12 0.485
FY 2017 Dec '17 2,009.22 0.256
Sep '17 2,246.99 5.223
Jun '17 2,148.73 0.318
Mar '17 2,126.03 0.382
 
*Note: Units in Millions ofRenminbi
**Note: Units in Renminbi

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 1 2,382.69 2,382.69 2,382.69 --
Quarter Ending Sep-19 1 2,470.75 2,470.75 2,470.75 --
Year Ending Dec-19 8 10,001.80 11,423.00 9,464.00 11,018.40
Year Ending Dec-20 10 11,356.00 13,122.00 10,146.00 12,666.90
Earnings (per share)
Quarter Ending Jun-19 1 0.43 0.43 0.43 0.42
Quarter Ending Sep-19 1 0.42 0.42 0.42 --
Year Ending Dec-19 9 1.73 2.05 1.53 1.80
Year Ending Dec-20 11 1.93 2.45 1.53 2.09
Sales and Profit Figures in China Yuan Renminbi (CNY);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 23.38 29.30 32.55
P/E High - Last 5 Yrs. 21.72 43.17 48.11
P/E Low - Last 5 Yrs. 19.33 22.71 23.41
Beta 0.64 0.86 0.87
Price to Sales (TTM) 3.15 6.59 8.43
Price to Book (MRQ) 3.08 5.12 5.27
Price to Tangible Book (MRQ) 3.97 5.84 6.74
Price to Cash Flow (TTM) -- 23.07 24.12
% Owned Institutions -- 0.87 1.65

Dividends

  Company industry sector
Dividend Yield 0.98 1.43 1.35
Dividend Yield - 5 Year Avg -- 1.45 1.37
Dividend 5 Year Growth Rate -- 4.00 4.71
Payout Ratio(TTM) 24.20 42.19 39.59

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 5.40 5.43 13.45
Sales (TTM) vs TTM 1 Yr. Ago 11.70 6.61 8.04
Sales - 5 Yr. Growth Rate 19.33 10.48 10.84
EPS (MRQ) vs Qtr. 1 Yr. Ago 17.38 46.17 48.21
EPS (TTM) vs TTM 1 Yr. Ago 8.92 -- --
EPS - 5 Yr. Growth Rate 15.99 9.90 10.46
Capital Spending - 5 Yr. Growth Rate 1.10 15.26 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.25 2.07 2.18
Current Ratio (MRQ) 1.38 2.87 2.98
LT Debt to Equity (MRQ) 0.01 8.87 11.35
Total Debt to Equity (MRQ) 10.87 12.87 16.04
Interest Coverage (TTM) 74.42 32.47 28.45

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 62.78 52.11 52.39
Gross Margin - 5 Yr. Avg. 62.03 49.67 50.39
EBITD Margin (TTM) 13.16 -- --
EBITD - 5 Yr. Avg 17.05 17.26 12.41
Operating Margin (TTM) 12.48 13.53 5.67
Operating Margin - 5 Yr. Avg. 11.49 13.69 8.00
Pre-Tax Margin (TTM) 14.12 11.88 4.69
Pre-Tax Margin - 5 Yr. Avg. 12.88 14.09 8.28
Net Profit Margin (TTM) 11.70 8.79 1.42
Net Profit Margin - 5 Yr. Avg. 10.72 10.58 4.69
Effective Tax Rate (TTM) 17.09 22.12 22.13
Effective Tax Rate - 5 Yr. Avg. 16.75 22.26 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) 1,517,735 928,393,106 819,596,351
Net Income/Employee (TTM) 177,612 105,138,317 92,773,650
Receivable Turnover (TTM) 4.88 5.84 5.82
Inventory Turnover (TTM) 2.85 2.57 3.42
Asset Turnover (TTM) 0.67 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 7.88 10.98 10.65
Return on Assets - 5 Yr. Avg. 8.66 12.41 11.77
Return on Investment (TTM) 16.23 14.23 13.82
Return on Investment - 5 Yr. Avg. 14.82 16.18 15.32
Return on Equity (TTM) 15.26 15.46 15.24
Return on Equity - 5 Yr. Avg. 14.96 17.07 16.41
  1 Year 3 Year 5 Year
Sales % 15.58 18.33 19.33
EPS (TTM) % 21.85 15.82 15.99
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Livzon Pharmaceutical Group Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 4.19 1.30 99 30
13 Week 1.47 -9.64 99 42
26 Week 24.57 6.23 99 43
52 Week 22.09 2.76 99 11
YTD 28.14 -0.94 99 39
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 12.33%
# of Holders: 53
Total Shares Held: 30,338,893
3 Mo. Net Change: -7,481,661
# New Positions: 0
# Closed Positions: 6
# Increased Positions: 8
# Reduced Positions: 18
# Net Buyers: -10
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.